Back to results
US 9,540,380 B2Granted
Imidazotriazinone compounds
AssigneeIronwood Pharmaceuticals, Inc.
InventorsRichard Chesworth, Gerhard Koenig, Amy Ripka, Gideon Shapiro
Life of this patent
Estimating the term…
Abstract
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.
Claims1
(+)-2-((3,4-trans)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.